Health and Medical News and Resources

General interest items edited by Janice Flahiff

How Common Immune Booster Works: Research May Lead to New and Improved Vaccines

How Common Immune Booster Works: Research May Lead to New and Improved Vaccines

From the March 14 2011 Science Daily news item

ScienceDaily (Mar. 14, 2011) — Alum is an adjuvant (immune booster) used in many common vaccines, and Canadian researchers have now discovered how it works. The research by scientists from the University of Calgary’s Faculty of Medicine is published in the March 13 online edition of Nature Medicine. The new findings will help the medical community produce more effective vaccines and may open the doors for creating new vaccines for diseases such as HIV or tuberculosis…

…Alum is a common grocery store staple used in pickling. It is very effective in inducing antibody responses and is the only human vaccine adjuvant approved for large-scale immunization. It has been in use for 90 years and appears in almost all vaccines we receive as without an adjuvant vaccines in general do not work.

For suggestions on how to get this article for free or at low cost click here

The International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) today gives its support to the 2011 WHO World Health Day, which this year takes as its theme Anti-Microbial Resistance (AMR) and raises awareness of the problem of antibiotics losing their effectiveness over time as bacteria naturally evolve and mutate to become resistant to drug treatments…

WHO has today called on governments and stakeholders to implement the policies and practices needed to prevent and counter the emergence of highly resistant infections, and also to provide appropriate care to those seriously affected by these microbes. The R&D-based pharmaceutical industry echoes that call and commits to play its part in addressing the challenge of AMR. Specifically, the IFPMA and its member companies and associations pledge the following:

  1. Continue our investment in R&D programs dedicated to the development of new antibacterial agents.
  2. Work in partnership towards a responsible global approach with UN Agencies (principally WHO), national governments, healthcare providers, NGOs and other stakeholders in the areas of education, prevention, innovation, access, financing and capacity-building initiatives.
  3. Support the WHO’s work to advise on the appropriate use of these vital medicines.

March 15, 2011 - Posted by | Public Health | , ,

No comments yet.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: